Buyer Guide• 6 min read
Peptide Blends Explained: Why GLOW, Wolverine & KLOW Combine Compounds
A peptide blend is a single lyophilized vial containing two or more synthesized peptides combined at fixed ratios. Blends are popular in laboratory tissue-repair research because they reduce reconstitution steps and lock in a consistent component ratio across study days.
Common research blends
- GLOW — GHK-Cu + BPC-157 + TB-500. Dermal remodeling + angiogenesis + cell migration.
- Wolverine — BPC-157 + TB-500. The classic soft-tissue repair pair without the dermal arm.
- KLOW — KPV + BPC-157 + TB-500 + GHK-Cu. Adds KPV's anti-inflammatory tripeptide signal to the GLOW base.
- CJC-1295 + Ipamorelin — GHRH analog plus GHRP for combined pituitary stimulation studies.
Why blends exist
Mechanistically, complementary peptides hit different arms of the tissue-repair cascade. Operationally, a blend removes the chance of mismatched reconstitution between two single-compound vials. For multi-week study designs, the ratio stays identical across every administration.
When a single-compound vial is the right call
- When the study isolates a single signaling pathway — a blend confounds the result
- When the dose curve for one component is the variable being tested
- When the published reference model used the single compound alone
Choosing a blend ratio
Most blends ship at 'common research ratios' established by precedent in the market rather than from controlled comparative studies. GLOW's 50/10/10 GHK-Cu/BPC-157/TB-500 ratio reflects relative per-mass potency in published in-vitro work, not a derived optimal mixture.